Search by Drug Name or NDC

NDC 68382-0594-05 perphenazine 16 mg/1 Details

perphenazine 16 mg/1

perphenazine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is PERPHENAZINE.

MedlinePlus Drug Summary

Perphenazine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Perphenazine is also used to control severe nausea and vomiting in adults. Perphenazine is in a class of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.

Related Packages: 68382-0594-05
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Perphenazine

Product Information

NDC	68382-0594
Product ID	68382-594_0aa00a79-3824-48b4-b106-754ce62d706f
Associated GPIs	59200045000320
GCN Sequence Number	003830
GCN Sequence Number Description	perphenazine TABLET 16 MG ORAL
HIC3	H2G
HIC3 Description	ANTIPSYCHOTICS,PHENOTHIAZINES
GCN	14650
HICL Sequence Number	001627
HICL Sequence Number Description	PERPHENAZINE
Brand/Generic	Generic
Proprietary Name	perphenazine
Proprietary Name Suffix	n/a
Non-Proprietary Name	perphenazine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	16
Active Ingredient Units	mg/1
Substance Name	PERPHENAZINE
Labeler Name	Zydus Pharmaceuticals (USA) Inc.
Pharmaceutical Class	Phenothiazine [EPC], Phenothiazines [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA205232
Listing Certified Through	2024-12-31

Package

NDC 68382-0594-05 (68382059405)

Pricing Information	N/A
NDC Package Code	68382-594-05
Billing NDC	68382059405
Package	500 TABLET in 1 BOTTLE (68382-594-05)
Marketing Start Date	2020-07-16
NDC Exclude Flag	N